Simin Guo
Beijing Key Laboratory For Quality Evaluation Of Chinese Materia Medica
Beijing, 100029, China
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "The interaction between polyphyllin I and SQLE protein induces hepatotoxicity through SREBP-2/HMGCR/SQLE/LSS pathway" [J. Pharm. Anal. 13 (2023) 39-54].
Journal: Journal of pharmaceutical analysis
Published: August 20, 2026
G22037, a novel oxadiazole-pyrazole derivative, attenuates liver fibrosis by targeting annexin A5 and inhibition of ER stress-dependent hepatic stellate cell activation.
Journal: Biochemical pharmacology
Published: April 02, 2026
Design, Synthesis, and Mechanistic Evaluation of l-Theanine Derivatives Targeting Cathepsin D for Anti-Hepatic Fibrosis.
Journal: Journal of medicinal chemistry
Published: February 09, 2026
Synthesis and Anti-Liver Fibrosis Research of Aspartic Acid Derivatives.
Journal: Molecules (Basel, Switzerland)
Published: August 21, 2024
Farnesoid X receptor modulator 12β-(m-methyl-benzoyl)-11,12-dihydro oleanolic acid represses liver fibrosis by inhibiting ERK/p38 signaling pathways.
Journal: Toxicology mechanisms and methods
Published: April 30, 2024
Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway.
Journal: Journal of pharmaceutical analysis
Published: April 10, 2024
The Chinese Clinical Sleep Database: An Innovative Database System Includes Large-Scale Clinical Data of Chinese Population.
Journal: Nature and science of sleep
Published: November 19, 2023
The interaction between polyphyllin I and SQLE protein induces hepatotoxicity through SREBP-2/HMGCR/SQLE/LSS pathway.
Journal: Journal of pharmaceutical analysis
Published: June 05, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026